Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
226,664,950
-
Total 13F shares
-
2,286,020
-
Share change
-
+139,284
-
Total reported value
-
$6,854,756
-
Price per share
-
$3.00
-
Number of holders
-
31
-
Value change
-
+$338,301
-
Number of buys
-
15
-
Number of sells
-
10
Institutional Holders of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) as of Q1 2020
As of 31 Mar 2020,
Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,286,020 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, STATE STREET CORP, UNITED CAPITAL FINANCIAL ADVISERS, LLC, DIMENSIONAL FUND ADVISORS LP, Bank of New York Mellon Corp, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and WELLS FARGO & COMPANY/MN.
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.